Literature DB >> 3556288

Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

D W Drell, A L Notkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3556288     DOI： 10.1007/BF00274217

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  144 in total

1.  Modulation of macrophage Fc receptor expression in vitro by insulin and cyclic nucleotides.

Authors:  J Rhodes
Journal:  Nature       Date:  1975-10-16       Impact factor: 49.962

2.  An antibody to low density lipoprotein in diabetics.

Authors:  E N Wardle
Journal:  Experientia       Date:  1978-07-15

3.  Reticuloendothelial system phagocytosis in diabetes mellitus.

Authors:  A Berken; A A Sherman
Journal:  Diabetes       Date:  1974-03       Impact factor: 9.461

4.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

5.  Streptozotocin effects on T lymphocytes and bone marrow cells.

Authors:  W K Nichols; L L Vann; J B Spellman
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

6.  Insulin treatment of newly-presenting ketotic diabetic patients into the honeymoon period.

Authors:  J P Hosker; R C Turner
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

7.  Autoimmunity in juvenile diabetics and their families.

Authors:  G F Bottazzo; J I Mann; M Thorogood; J D Baum; D Doniach
Journal:  Br Med J       Date:  1978-07-15

8.  Antimicrosomal antibodies, gastric parietal cell antibodies and antinuclear factors in insulin dependent diabetes mellitus.

Authors:  K Nagaoka; T Sakurami; N Nabeya; H Imura; S Kuno
Journal:  Endocrinol Jpn       Date:  1979-10

9.  [Islet-cell antibodies and organ-specific antibodies in diabetic children and adolescents. Relationship with age, age at onset, duration of diabetes, residual insulin secretion and retinopathy (author's transl)].

Authors:  H Dorchy; B Lemiere; D Toussaint; P Gausset
Journal:  Nouv Presse Med       Date:  1981-09-26

10.  Studies on the effect of experimental nonketotic diabetes mellitus on antibacterial defense. I. Demonstration of a defect in phagocytosis.

Authors:  R H Drachman; R K Root; W B Wood
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307
View more
  50 in total

1.  Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.

Authors:  G Triolo; E Giardina; D Casiglia; G Scarantino; G D Bompiani
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

2.  Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens.

Authors:  Hiroki Hirai; Junnosuke Miura; Yafang Hu; Helena Larsson; Karin Larsson; Ake Lernmark; Sten-A Ivarsson; Tianxia Wu; Albert Kingman; Athanasios G Tzioufas; Abner L Notkins
Journal:  Clin Immunol       Date:  2008-03-24       Impact factor: 3.969

Review 3.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

4.  Expression of a viral gene in insulin-producing cell lines renders them susceptible to immunological destruction.

Authors:  M Shibata; A Puga; K F Salata; C J Bachurski; M I Lerman; A L Notkins
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

Review 5.  The skin in diabetes mellitus.

Authors:  M J Goodfield; L G Millard
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

Review 6.  Premises for immune interventional therapy in rheumatoid arthritis.

Authors:  I R Mackay; M J Rowley
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

7.  Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.

Authors:  C Thivolet; B Beaufrére; H Bétuel; L Gebuhrer; P Chatelain; A Durand; J Tourniaire; R François
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

8.  Preclinical and manifest diabetes mellitus in young patients with Friedreich's ataxia: no evidence of immune process behind the islet cell destruction.

Authors:  E J Schoenle; E J Boltshauser; S Baekkeskov; M Landin Olsson; T Torresani; A von Felten
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

9.  High serum levels of soluble CD8 in insulin-dependent diabetes.

Authors:  E Di Cesare; M Previti; M C Ingemi; G F Bagnato; D Cucinotta
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

10.  Cancer risk in patients with diabetes mellitus.

Authors:  H O Adami; J McLaughlin; A Ekbom; C Berne; D Silverman; D Hacker; I Persson
Journal:  Cancer Causes Control       Date:  1991-09       Impact factor: 2.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.